DocSym
β
Searchsearch
Search
(P58.4) Neonatal jaundice due to drugs or toxins transmitted from mother or given to newborn
More details coming soon
675 518 in individuals diagnosis neonatal jaundice due to drugs or toxins transmitted from mother or given to newborn confirmed
Diagnosis neonatal jaundice due to drugs or toxins transmitted from mother or given to newborn is diagnosed Men are 13.21% more likely than Women
382 373
Men receive the diagnosis neonatal jaundice due to drugs or toxins transmitted from mother or given to newborn
0 (less than 0.1%)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
293 145
Women receive the diagnosis neonatal jaundice due to drugs or toxins transmitted from mother or given to newborn
0 (less than 0.1%)Died from this diagnosis.
Risk Group for the Disease neonatal jaundice due to drugs or toxins transmitted from mother or given to newborn - Men and Women aged 0
In Men diagnosis is most often set at age 0-5
Less common in men the disease occurs at Age 5-95+Less common in women the disease occurs at Age 0-19, 25-34, 40-95+
In Women diagnosis is most often set at age 0-1, 20-24, 35-39
Disease Features neonatal jaundice due to drugs or toxins transmitted from mother or given to newborn
Absence or low individual and public risk
Neonatal jaundice due to drugs or toxins transmitted from mother or given to newborn - what does this mean
Neonatal jaundice due to drugs or toxins transmitted from mother or given to newborn occurs when the newborn is exposed to drugs or toxins that are either passed from the mother during pregnancy or given to the newborn at birth. this can cause an increase in the level of bilirubin in the newborn's blood, leading to jaundice.
What happens during the disease - neonatal jaundice due to drugs or toxins transmitted from mother or given to newborn
Neonatal jaundice due to drugs or toxins transmitted from mother or given to newborn is caused by a buildup of bilirubin in the newborn’s body. this is caused by the drugs or toxins that are passed from the mother to the newborn either through the placenta or via the newborn's ingestion of the drug or toxin. the bilirubin is unable to be broken down and processed by the newborn's liver, resulting in a buildup of the bilirubin in the bloodstream. this causes the newborn to have a yellowish tint to their skin, which is a sign of jaundice.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Physical examination of newborn
- Blood tests to measure bilirubin levels
- Urine tests to check for toxins
- Liver function tests
- Toxicology tests to check for drug exposure
- Ultrasound of the abdomen
- CT scan of the abdomen
- MRI of the abdomen
Treatment and Medical Assistance
Main Goal: Treat Neonatal Jaundice due to drugs or toxins transmitted from mother or given to newborn.
- Administer phototherapy to reduce bilirubin levels
- Exchange transfusion to remove bilirubin from the bloodstream
- Provide nutritional support and fluids to the infant
- Administer medications to reduce the amount of bilirubin in the blood
- Monitor the infant's response to treatment
- Educate the parents about the treatment and the disease
- Provide follow-up care and monitoring
12 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Neonatal jaundice due to drugs or toxins transmitted from mother or given to newborn - Prevention
The best way to prevent neonatal jaundice due to drugs or toxins transmitted from mother or given to newborn is to ensure that pregnant women receive adequate prenatal care and screening. this includes regular monitoring of the mother's health and any medications she may be taking, and avoiding the use of any drugs or toxins that could be passed on to the newborn. additionally, any medications or treatments given to the newborn should be carefully monitored by the healthcare team to ensure they are safe and effective.